Key points are not available for this paper at this time.
Bacteria belonging to the genus Klebsiella frequently cause human nosocomial infections. In particular, the medically most important Klebsiella species, Klebsiella pneumoniae, accounts for a significant proportion of hospital-acquired urinary tract infections, pneumonia, septicemias, and soft tissue infections. The principal pathogenic reservoirs for transmission of Klebsiella are the gastrointestinal tract and the hands of hospital personnel. Because of their ability to spread rapidly in the hospital environment, these bacteria tend to cause nosocomial outbreaks. Hospital outbreaks of multidrug-resistant Klebsiella spp., especially those in neonatal wards, are often caused by new types of strains, the so-called extended-spectrum-beta-lactamase (ESBL) producers. The incidence of ESBL-producing strains among clinical Klebsiella isolates has been steadily increasing over the past years. The resulting limitations on the therapeutic options demand new measures for the management of Klebsiella hospital infections. While the different typing methods are useful epidemiological tools for infection control, recent findings about Klebsiella virulence factors have provided new insights into the pathogenic strategies of these bacteria. Klebsiella pathogenicity factors such as capsules or lipopolysaccharides are presently considered to be promising candidates for vaccination efforts that may serve as immunological infection control measures.
Building similarity graph...
Analyzing shared references across papers
Loading...
Rainer Podschun
U. Ullmann
Clinical Microbiology Reviews
Kiel University
Building similarity graph...
Analyzing shared references across papers
Loading...
Podschun et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d7cd1ca2a48916bbbedb1a — DOI: https://doi.org/10.1128/cmr.11.4.589
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: